FDA NDC Directory · JSON-LD · Markdown

BRIUMVI

NDC 73150-150 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Generic nameublituximab
Labeler / ManufacturerTG Therapeutics, Inc.
Marketing categoryBiologic License Application · App BLA761238
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsUBLITUXIMAB (150 mg/6mL)
Marketing started20221228
Package count1

External sources

Source: openFDA. Public-domain (CC0).